Breaking News

We're getting closer to cancer vaccines

October 29, 2024
Leading a recharged field, from left, Uğur Şahin and Özlem Türeci from BioNTech,  and Catherine Wu from Dana-Farber.
Photo illustration: Christine Kao/STAT; Photos: Getty, Adobe, Sam Ogden

STAT+ | Dreams of cancer vaccines are becoming more real. Here are 9 scientists making it happen 

STAT profile series looks at movers and shakers in various fields: Here are nine researchers on the cutting edge of cancer vaccine research.

By Angus Chen


STAT+ | Warren wants close FTC scrutiny of drug distributors buying cancer medical groups

Elizabeth Warren argues that patients could lose in deals that get middlemen McKesson, Cardinal Health, and Cencora into cancer care.

By Bob Herman


6 races to watch that could shape health care policy

Affordability and drug pricing transparency are cited by some candidates in key congressional races, while others are relatively pharma-friendly.

By Rachel Cohrs Zhang



Pfizer CEO Albert Bourla
STAT

STAT+ | Pfizer beats earnings expectations in first report after criticism by activist investor

Pfizer reported earnings for the first time since an activist investor took a $1 billion stake in the drug giant.

By Matthew Herper


D.C. Diagnosis: Could RFK Jr. go 'wild' on health and medicine?

What's new in health politics and policy? Trump's Joe Rogan interview, the Medicare director on drug reform, and the return of "bad genes."

By Sarah Owermohle


STAT+ | VCs move to launch U.S.-based companies to advance drugs developed in China

As Chinese biopharma companies rise on the international stage, they are increasingly finding VC partners — in the United States.

By Brian Yang


Jenny Kane/AP

Q&A: Why drafting new rules on ultra-processed foods is so hard

To study potential harm of ultra-processed foods, randomized trials have to be very large and very long to get answers about prevention of chronic diseases.

By Elizabeth Cooney


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2024, All Rights Reserved.

No comments